Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Keynote and panel discussion on communicating heterogeneous treatment effects across populations

James Heyward, Milena Lolic, Catherine Spong, David Atkins, Gene Pennello, Ravi Varadhan

Research output: Contribution to journalArticlepeer-review

Abstract

How do we communicate nuanced regulatory information to different audiences, recognizing that the consumer audience is very different from the physician audience? In particular, how do we communicate the heterogeneity of treatment effects - the potential differences in treatment effects based on sex, race, and age? That is a fundamental question at the heart of this panel discussion. Each panelist addressed a specific “challenge question” during their 5-minute presentation, and the list of questions is provided. The presentations were followed by a question and answer session with members of the audience and the panelists.

Original languageEnglish (US)
JournalPharmaceutical Statistics
DOIs
StateAccepted/In press - 2021

Keywords

  • clinical trials
  • drug trial snapshot
  • subgroup analysis
  • treatment effects

ASJC Scopus subject areas

  • Statistics and Probability
  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Keynote and panel discussion on communicating heterogeneous treatment effects across populations'. Together they form a unique fingerprint.

Cite this